Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Ranibizumab

Brand: 
NICE TA: 283
Indication: Macular Oedema - retinal vein occlusion (NICE TA283)
Disease category: Eye
Commissioning responsibility: CCG
PbR excluded: Yes

Background

CCGs should only fund treatment obtained through the patient access scheme

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine available through a PAS

Supporting documents:

NICE TA283 - Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion

 

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red